Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care

Abstract

Background Cancer survivors represent a growing population, heterogeneous in their need for medical care, psychosocial support, and practical assistance. To inform survivorship research and practice, this manuscript will describe the prevalent population of cancer survivors in terms of overall numbers and prevalence by cancer site and time since diagnosis. Methods Incidence and survival data from 1975–2007 were obtained from the Surveillance, Epidemiology, and End Results Program and population projections from the United States (US) Census Bureau. Cancer prevalence for 2012 and beyond was estimated using the Prevalence Incidence Approach Model, assuming constant future incidence and survival trends but dynamic projections of the US population. Results As of January 1, 2012, approximately 13.7 million cancer survivors were living in the US with prevalence projected to approach 18 million by 2022. Sixty-four percent of this population have survived ≥ 5 years; 40% have survived ≥ 10 years; and 15% have survived ≥ 20 years after diagnosis. Over the next decade, the number of people who have lived ≥ 5 years after their cancer diagnosis is projected to increase approximately 37% to 11.9 million. Conclusions A coordinated agenda for research and practice is needed to address cancer survivors’ long-term medical, psychosocial, and practical needs across the survivorship trajectory. Impact Prevalence estimates for cancer survivors across the survivorship trajectory will inform the national research agenda as well as future projections about the health service needs of this population.

Sexual Health as a Survivorship Issue for Female Cancer Survivors

“…Fortunately, most patients can be expected to do quite well following diagnosis, with a 5-year survival rate of approximately 70% across all tumor types [2]. Current estimates in the U.S. alone indicate that 64%, 40%, and 15% of cancer survivors are alive 5 years, 10 years, and 20 years or more, respectively, following diagnosis [3]. As a result, almost 13 million people in the U.S. and 30 million people globally are living beyond cancer [4].…”

Cancer survivorship programs: time for concerted action

“…2 The US has 13 million cancer survivors and expects to have 18 million by 2022. 3 A similar trend is apparent in Europe and across the world, intensified by the shift in age demographics. In the UK, for example, 25% of all people aged over 65 years are expected to be diagnosed with cancer by 2040; many of them will survive and face novel problems.…”

Prevention and Monitoring of Cardiovascular Complications in Patients With Luminal Her2-Negative Metastatic Breast Cancer

“…Также необходимо понимать, что пациенты, перенесшие химиотерапевтическое лече-ние, лучевую терапию и получавшие таргетную тера-пию (например, трастузумабом), могут иметь скрытые, недиагностированные ССЗ [4][5][6]. При этом женщины старшего возраста из этой группы чаще умирают от других болезней, и ССЗ являются наиболее частой причиной [7][8][9]. Более 20 % пациенток с РМЖ в воз-расте 65-74 лет погибают не от прогрессирования основного заболевания, а от сопутствующей сердечно-сосудистой патологии [10].…”